CytoMed Therapeutics Limited

GDTC Health Care Biotechnology: Pharmaceutical Preparations

$0.92

▲ +5.4% Today

as of Oct 22, 16:48 ET

Last 30 days +7.86% Sep 14 → Oct 22

Open

$0.88

High

$0.92

Low

$0.82

Volume

$5,633

Avg Vol

$182,002

Mkt Cap

$12M

P/E (TTM)

—

Beta

—

52w High

$3.10

52w Low

$0.68

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 2 items

Oct 9 · 20:57 MT Newswires

CytoMed Therapeutics Gets Nasdaq Minimum Bid Price Deficiency Notice

Oct 9 · 20:30 PR GlobeNewswire

CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

GDTC earnings at a glance

The share price of $0.92 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range

$0.68

$3.10

10% of range

Avg surprise (last 0)

—

Avg reaction (last 0)

—

Earnings trends

Implied volatility — last 90 days

No IV snapshots yet for GDTC.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

Aspire-Lakewood Holdings, Inc.

Kiora Pharmaceuticals, Inc.

$11M $2.32-0.4%

MBRX

Moleculin Biotech, Inc.

$10M $5.89-6.7%

LEXX

Lexaria Bioscience Corp.

$14M $2.99+12.8%

View on Nasdaq ↗